From vaccines and pharmaceuticals, to biofuels, food and household goods, developments in bioprocessing and biotechnology have the potential to significantly influence the future of manufacturing, medicine and energy. Significant challenges remain in many areas, such as complex regulatory issues and the ever-present need to improve productivity and consistency, whilst reducing costs, resulting in the generation of highly valuable and eminently protectable innovation for our clients.
Progress in bioprocessing within the pharmaceutical sector is motivated by a growing demand for novel therapeutics, including biopharmaceutical medicines and vaccines, and the rapid emergence of disruptive cell and gene therapy treatments.
In the energy sector, research and development is spurred by public desire and government support for more efficient, cleaner systems that enable a shift away from traditional petrochemicals.
And in food and nutrition, growing demands for meat replacements, increased shelf life, enhanced quality and health-promoting products are all influencing a range of technological developments.
These, and other areas of bioprocessing and biotechnology, are underpinned by a plethora of technologies, from vector design to process control, fermenter engineering to product recovery. HGF has been at the cutting-edge of developments in bioprocessing and biotechnology for many years, with a specialist team combining comprehensive scientific knowledge and commercial understanding to develop and implement legally and commercially astute IP strategies. Working with a wide range of clients, from global pharmaceutical and biotech companies, to SMEs and universities, the team supports innovation across all sectors.
HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …Event details
In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’ for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …Read article
The Microbiome & Probiotic R&D & Business Collaboration Forum is set to take place in Rotterdam on the 23rd-24th April 2024. This world-renowned event will see three conferences and eight …Event details
IAM Patent 1000 the world’s leading patent professionals 2023 guide has now been published and we are delighted to have 31 attorneys recognised as world-class individuals in the guide. The …Read article
The “European database on medical devices”, or “EUDAMED”, is the EU’s IT system created by the new Medical Devices Regulation (MDR) and In Vitro Diagnostics Medical Devices Regulation (IVDR). When …Read article
The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …Event details
HGF is a silver sponsor of LSPN Europe 2022 on 29th November in London. This event will explore some of the biggest challenges facing the Life Sciences Patent Community right now …Event details
Case study – alt fat innovation Many companies and investors are aware of the importance of identifying and protecting their innovations, and in particular of the importance of obtaining patents …Read article